Interestingly, we identified two neoantigen candidates in two patients (ImmuNEO-4 and −23) that were derived from shared variants in MAP4K5 (IN_04_F, 1.5% FDR; shared between 32 tumor samples; Supplementary Data 2) and in AC024075.2 (IN_23_A, 4.3% FDR, shared between 24 tumor samples; Supplementary Data 2), respectively. The gene discussed is MAP4K5; the disease is neoplasm.